Clinical reference Biomarker Directory
Back to directory

Pancreatic Polypeptide

Emerging

Pancreatic polypeptide supports PPoma diagnosis, typically as part of a broader neuroendocrine tumor marker panel.

Also known as PP pancreatic polypeptide
In plain language

Pancreatic polypeptide is a hormone from the pancreas. Very high levels can point to a rare pancreatic tumor, though this test is almost always used alongside other neuroendocrine tumor markers rather than by itself.

Biomarker & context

Pancreatic polypeptide (PP) is secreted by specialized pancreatic islet cells (PP cells) and helps regulate pancreatic secretion and appetite.

What it indicates

Markedly elevated pancreatic polypeptide supports diagnosis of a PPoma, a rare pancreatic neuroendocrine tumor, and it's sometimes included in broader neuroendocrine tumor marker panels alongside chromogranin A (discussed earlier).

Diagnosis & clinical testing

Measured via serum immunoassay, typically as part of a neuroendocrine tumor marker panel rather than in isolation, since it's rarely diagnostic by itself.

Guiding treatment

Elevated PP in a patient with a pancreatic mass supports pursuing further neuroendocrine tumor workup (imaging, chromogranin A, and other markers) to characterize the tumor before treatment planning.

Clinical significance

Rarely diagnostic in isolation; used alongside chromogranin A and other markers for full characterization.

References
  1. General endocrine oncology reference literature on pancreatic polypeptide in PPoma and neuroendocrine tumor panels.